Makary resignation - review risk

0.44 on the curve spread is the clean macro tell after reports said F.D.A. Commissioner Marty Makary resigned reuters.com, with the long-end yield at 4.38 and the front-end yield at 3.94fred.stlouisfed.org fred.stlouisfed.org fred.stlouisfed.org): this reads as healthcare regulatory risk, not a macro shock. The beat for risk is continuity on review calendars and approval standards; the miss is any official sign those may shift, which could widen single-name healthcare dispersion.

0.44 on the curve spread is the clean macro tell after reports said F.D.A. Commissioner Marty Makary resigned reuters.com, with the long-end yield at 4.38 and the front-end yield at 3.94fred.stlouisfed.org fred.stlouisfed.org fred.stlouisfed.org): this is trading like a healthcare regulatory shock, not a macro one. The beat for risk is a continuity message from the White House and the agency, which would argue for the story staying in single-name biotech, pharma, and medtech dispersion; the miss is any suggestion that review calendars, approval standards, or enforcement priorities are being reset, which could widen the move into broader healthcare risk. That is why the first read usually runs through pending catalyst names rather than rates or index beta: the market is trying to price leadership uncertainty around the decision pipeline, not a change in aggregate demand or inflation. The base-case read may be higher dispersion, not automatic sector beta down. What could change the tape from headline noise to repricing is an official signal that the replacement or interim setup will change how pending decisions are handled.